SynthesisBMC health services research2026
Health system barriers and facilitators influencing the uptake of cervical cancer screening among women in sub-Saharan Africa: systematic review and meta-synthesis.
Synthesis in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Qualitative Analysis of Factors Contributing to Cervical Cancer Screening Implementation in Health Care Facilities in Uganda.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCervical cancer ranks among the most frequent cancers and is the fourth leading cause of death among women globally. In Sub-Saharan Africa (SSA), it is the leading cause of cancer-related mortality for women. Although there are primary and secondary preventative interventions available, they are not widely used. This systematic review and meta-synthesis aimed to identify health system barriers and facilitators that influence the uptake of cervical cancer screening among women in SSA.
methodsA comprehensive search was conducted across four electronic databases to identify English-language papers that highlighted health system barriers and facilitators that impact women in SS. As uptake of cervical cancer screening. Health system barriers and facilitators were extracted and categorized using the World Health Organization’s (WHO) Health Systems Framework: service delivery, health workforce, health information, medical products and technologies, financing, and leadership/governance. The review was carried out following the methodology for systematic reviews and reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
resultsSeven qualitative studies were included in this review. The five categories under which these elements of the health system were categorized were the delivery of health services, the health workforce, health system financing, the health information system, and necessary medications and technology. The most frequent barriers preventing women from getting screened for cervical cancer were those related to the health workforce (lack of appropriate personnel trained in cervical cancer screening), and the health service delivery (lack of screening services in health facilities and long travel distance to screening centres) while the health information system (information from healthcare providers on screening) was identified as a key facilitator for cervical cancer screening.
conclusionThis review concluded that key health system barriers, such as a lack of properly trained personnel in cervical cancer screening, screening centers, qualified health professionals, and a high cost of consultation, hindered women from accessing screening for cervical cancer in SSA. Resolving these highlighted health system limitations should be the primary focus of strategies to increase cervical screening adoption and usage in SSA. Our review found limited qualitative attention to the treatment and follow-up pathway; strengthening screening programs must include investments in referral systems, diagnostic capacity, and affordable treatment services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.